ArticleCurrent protocols2025
A Novel Image-Based Approach for Analyzing Neutrophil Chemotaxis Using a Boyden Chamber Assay.
Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Image-Based Approach for Analyzing Neutrophil Chemotaxis Using a Boyden Chamber Assay.Current protocols · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemotaxis is a fundamental biological process in which cells such as leukocytes migrate directionally from one site to another in response to a chemical gradient. This process of cellular migration is critical for execution of appropriate physiological responses to inflammation, as observed during immune defense and wound healing responses. Neutrophils being the first responders to the sites of infection or injury are one such type of cells. A neutrophil chemotaxis assay is a commonly used laboratory technique used to measure the directed movement of neutrophils toward a chemical signal termed a chemoattractant. It is used in immunology and inflammation research to study directed immune cell migration and to assess the effects of various molecules on cell migration. When studying neutrophil chemotaxis, current methods rely on counts of cells that have migrated across a membrane or substrate and observation of the migrated cells under a microscope. While useful, this approach fails to account for cells that have been activated but remain adherent to the substrate or cells that are in the intermediate stages of transmigration. Such limitations restrict the scope of information obtained and may lead to incomplete interpretations of neutrophil chemotaxis. To address this, we developed a new image analysis method that directly addresses the membrane in a chemotaxis chamber called the Boyden chamber. This improved technique allows quantification of neutrophils that have migrated as well as those that are adherent or actively transmigrating. By including all three stages of neutrophil movement, it provides a more comprehensive and physiologically relevant understanding of chemotaxis. It offers researchers a powerful tool to dissect the dynamics of immune cell behavior with greater sensitivity and accuracy, paving the way for deeper insights into immune responses and potential therapeutic interventions in inflammatory diseases. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Assay for the migration of bone marrow-derived neutrophils using the Boyden chamber Basic Protocol 2: Analysis of adherent, transmigrating, and transmigrated cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.